Frontlight ResearchEarly access
Huntington's disease trials in New Zealand
2 of 4 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease
- Where
- Christchurch
- Age
- 21 years to 70 years
- People
- 32 worldwide
- Run by
- Sarepta Therapeutics, Inc.
See details and how to joinNCT07536061 - Phase 2/3Enrolling by invitationAn Extension of SKY-0515 in Participants With Huntington's Disease
- Where
- Auckland, Christchurch, Wellington
- Age
- 25 years and over
- People
- 500 worldwide
- Run by
- Skyhawk Therapeutics, Inc.
See details and how to joinNCT07537075